Abiopharma

Xenetic Biosciences, Inc. Reports Full Year 2025 Financial Results

KORU Medical Systems Announces EU MDR Certification for theFreedom60® Infusion Pump With Prefilled Syringe Compatibility

Director Parsons James T. 🟢 acquired 10.0K shares of ONCOLYTICS BIOTECH INC (ONCY) at $1.03 Transaction Date: Mar 11, 2026 | Filing ID: 009983

bioAffinity Technologies Announces Record 2025 Revenue and Unit Sales for Flagship Lung Cancer Diagnostic CyPath® Lung

Kestrel Group Reports Fourth Quarter and Full Year 2025 Financial Results

Liberty Live Holdings, Inc. Enters into Exchange Agreements with Certain Holders of its 2.375% Exchangeable Senior Debentures due 2053

Xenetic Biosciences, Inc. Reports Full Year 2025 Financial Results

Real’s Monthly Agent Survey: Agents Forecast Stronger Spring Selling Season

Lifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed—Creating Diversified Biomedical Company

Elutia Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

Lumentum Thought Leaders to Present at OFC 2026

Origin Materials Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call

Uber and Motional Launch Robotaxi Service in Las Vegas

Newegg Opens Public Gamer Zone, Expanding Gaming, Esports, and Tech Education in Southern California

SBC Medical to Announce Q4 and Full‑Year 2025 Financial Results